KDM2B-IN-3
KDM2B-IN-3 is a histone demethylase KDM2B inhibitor extracted from patent WO2016112284A1, compound 183c. KDM2B-IN-3 can be used for the research of cancer[1].
Product Specifications
CAS Number
[1966933-87-8]
UNSPSC
12352005
Target
Histone Demethylase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kdm2b-in-3.html
Solubility
10 mM in DMSO
Smiles
N#CCC1=C(OC)C=CC2=C1C=CC(C([C@@H]3[C@H](CCN(C4CCC4)C3)CC)=O)=C2
Molecular Formula
C25H30N2O2
Molecular Weight
390.52
References & Citations
[1]Albrecht BK, et, al. (piperidin-3-yl) (naphthalen-2-yl) methanone derivatives and related compounds as inhibitors of the histone demethylase kdm2b for the treatment of cancer. WO2016112284A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
KDM2
More Discoveries
Explore Other Products
Browse additional items from our catalog